$HNSA #Hansa Biopharma AB Hansa Biopharma - All eyes on EMA: We expect CHMP opinion 25-28 May and approval Q3’20 Q2’20 highlights Estimates unchanged, reiterate BUY https://t.co/ghET4V4RQk #equity #stocks https://t.co/VpoPiAZtFh